36 results
SC 14D9
NGM
Ngm Biopharmaceuticals Inc
8 Mar 24
Tender offer solicitation
5:21pm
joining Merck, Dr. Perlmutter spent 12 years as Executive Vice President and head of R&D at Amgen from January 2001 to February 2012. Prior to assuming
8-K
EX-99.1
f7dgfu zjch
3 Aug 23
NGM Bio Reports Second Quarter 2023 Financial Results and Provides Business Highlights
4:07pm
8-K
EX-99.1
gir7x
4 May 23
NGM Bio Reports First Quarter 2023 Financial Results and Provides Business Highlights, Including Topline ALPINE 4 Data
4:11pm
8-K
EX-99.1
33rhw0lpvh
3 Nov 22
NGM Bio Provides Business Highlights and Reports Third Quarter 2022 Financial Results
4:12pm
8-K
EX-99.1
c9r9p7ss4i
4 Aug 22
NGM Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results
4:13pm
8-K
EX-99.1
ar4l2fxp
5 May 22
NGM Bio Provides Business Highlights and Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
lucou orl3yit
1 Mar 22
NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results
4:11pm
8-K
EX-99.1
mssvsdey988bov vt36
4 Nov 21
NGM Bio Provides Business Highlights and Reports Third Quarter 2021 Financial Results
4:16pm